GlaxoSmithKline Plc Monday reached an agreement with Merck for the acquisition of marketing rights for Mecavor in the United States.
A younger generation of chief executives in many boardrooms is set to spur the strategic overhaul.
China went on a charm offensive on Wednesday to convince a skeptical world its products are safe, as a new poll in the United States found 78 percent of Americans were worried about the safety of Chinese goods.
GlaxoSmithKline Plc's diabetes drug Avandia should stay on the U.S. market, even though data suggest it may increase the risk of a heart attack for some patients, an advisory panel said on Monday in a 22-1 vote.
GlaxoSmithKline Plc's widely used diabetes drug Avandia should be pulled off the market, U.S. Food and Drug Administration scientist David Graham said in a presentation prepared for delivery on Monday.
The U.S. Food and Drug Administration will ask outside advisers if GlaxoSmithKline Plc's diabetes drug Avandia should be taken off the market or remain on sale with new warnings or limits, a summary released on Thursday said.
The first U.S. non-prescription weight loss pill was approved this week by U.S. health officials.
GlaxoSmithKline won a partial victory on Wednesday in its bid to stop Spanish drug wholesalers from re-exporting its medicines at high premiums.
GlaxoSmithKine plc has announced today the submission of a New Drug Application to the United States Food and Drug Administration (FDA), for approval to market.
GlaxoSmithKline Plc, the world's leading maker of HIV/AIDS treatments, has struck a deal to supply cut price AIDS drugs to Russia
The first vaccine to prevent cervical cancer won U.S. approval on Thursday when health officials cleared a Merck & Co. Inc. shot to block a sexually transmitted infection that causes the deadly disease.
German drugs and chemicals group Bayer is not currently considering a bid for Pfizer's consumer healthcare business, an industry source familiar with the matter told Reuters on Saturday.
